Ying Ma

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Jihui Hao · 5 shared papers, 2021–2025 · strength 0.90
   • Paper Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancrea… DOI 10.3791/67413↗
   • Paper Integrating tertiary lymphoid structure-associated genes into computational models to evaluate prognostication and immu… DOI 10.1093/jleuko/qiae067↗
   • Paper Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppr… DOI 10.1038/s41422-025-01098-4↗
2. Xiangqin Zhao · 3 shared papers, 2024–2025 · strength 0.67
   • Paper Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancrea… DOI 10.3791/67413↗
   • Paper Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer. DOI 10.1016/j.isci.2024.111085↗
   • Paper Integrating tertiary lymphoid structure-associated genes into computational models to evaluate prognostication and immu… DOI 10.1093/jleuko/qiae067↗
3. Jin Zhang · 2 shared papers, 2023–2024 · strength 0.46
   • Paper Anoikis-Related Gene Signature for Prognostication of Pancreatic Adenocarcinoma: A Multi-Omics Exploration and Verifica… DOI 10.3390/cancers15123146↗
   • Paper Integrating tertiary lymphoid structure-associated genes into computational models to evaluate prognostication and immu… DOI 10.1093/jleuko/qiae067↗
4. Chongbiao Huang · 3 shared papers, 2021–2025 · strength 0.44
   • Paper Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppr… DOI 10.1038/s41422-025-01098-4↗
   • Paper Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2023.0039↗
   • Paper CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanis… DOI 10.1016/j.canlet.2021.07.024↗
5. Xiuchao Wang · 3 shared papers, 2021–2025 · strength 0.44
   • Paper Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppr… DOI 10.1038/s41422-025-01098-4↗
   • Paper Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2023.0039↗
   • Paper CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanis… DOI 10.1016/j.canlet.2021.07.024↗
6. Tiansuo Zhao · 3 shared papers, 2021–2025 · strength 0.44
   • Paper Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppr… DOI 10.1038/s41422-025-01098-4↗
   • Paper Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2023.0039↗
   • Paper CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanis… DOI 10.1016/j.canlet.2021.07.024↗
7. Craig D. Logsdon · 4 shared papers, 2011–2024 · strength 0.33
   • Paper Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer. DOI 10.1016/j.isci.2024.111085↗
   • Paper Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. DOI 10.1158/0008-5472.can-12-4479↗
   • Paper Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. DOI 10.1186/1756-8722-5-15↗
8. Patrick Hwu · 3 shared papers, 2011–2024 · strength 0.28
   • Paper Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer. DOI 10.1016/j.isci.2024.111085↗
   • Paper Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. DOI 10.1186/1756-8722-5-15↗
   • Paper Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. DOI 10.1158/1078-0432.ccr-11-0607↗
9. Baoan Ji · 3 shared papers, 2011–2024 · strength 0.28
   • Paper Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer. DOI 10.1016/j.isci.2024.111085↗
   • Paper Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. DOI 10.1186/1756-8722-5-15↗
   • Paper Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. DOI 10.1158/1078-0432.ccr-11-0607↗
10. Shengyu Yang · 2 shared papers, 2021–2023 · strength 0.25
    • Paper Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2023.0039↗
    • Paper CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanis… DOI 10.1016/j.canlet.2021.07.024↗
11. Song Gao · 2 shared papers, 2021–2023 · strength 0.25
    • Paper Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2023.0039↗
    • Paper CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanis… DOI 10.1016/j.canlet.2021.07.024↗
12. Huamin Wang · 4 shared papers, 2011–2020 · strength 0.23
    • Paper Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic … DOI 10.1053/j.gastro.2020.03.018↗
    • Paper Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer th… DOI 10.1016/j.biomaterials.2018.01.014↗
    • Paper Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. DOI 10.1186/1756-8722-5-15↗
13. Huamin Wang · 1 shared paper, 2024 · strength 0.22
    • Paper Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer. DOI 10.1016/j.isci.2024.111085↗
14. Stephen E. Ullrich · 3 shared papers, 2013–2018 · strength 0.20
    • Paper Intratumoral mast cells promote the growth of pancreatic cancer. DOI 10.4161/onci.25964↗
    • Paper Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer th… DOI 10.1016/j.biomaterials.2018.01.014↗
    • Paper Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. DOI 10.1158/0008-5472.can-12-4479↗
15. Kaiyuan Wang · 1 shared paper, 2025 · strength 0.19
    • Paper Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppr… DOI 10.1038/s41422-025-01098-4↗
16. Bo Ni · 1 shared paper, 2025 · strength 0.19
    • Paper Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppr… DOI 10.1038/s41422-025-01098-4↗
17. Yongjie Xie · 1 shared paper, 2025 · strength 0.19
    • Paper Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppr… DOI 10.1038/s41422-025-01098-4↗
18. Tianxing Zhou · 1 shared paper, 2025 · strength 0.19
    • Paper Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppr… DOI 10.1038/s41422-025-01098-4↗
19. Chao Yang · 1 shared paper, 2025 · strength 0.19
    • Paper Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppr… DOI 10.1038/s41422-025-01098-4↗
20. Anirban Maitra · 2 shared papers, 2018–2020 · strength 0.17
    • Paper Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic … DOI 10.1053/j.gastro.2020.03.018↗
    • Paper Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer th… DOI 10.1016/j.biomaterials.2018.01.014↗
21. Danqi Fu · 1 shared paper, 2023 · strength 0.14
    • Paper Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2023.0039↗
22. Jinsheng Ding · 1 shared paper, 2023 · strength 0.14
    • Paper Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2023.0039↗
23. Bo Tang · 1 shared paper, 2023 · strength 0.14
    • Paper Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2023.0039↗
24. Chuntao Gao · 1 shared paper, 2023 · strength 0.14
    • Paper Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2023.0039↗
25. Jing Liu · 1 shared paper, 2023 · strength 0.14
    • Paper Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. DOI 10.20892/j.issn.2095-3941.2023.0039↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.